Ondansetron Hydrochloride

DRUG10 trials

Conditions

Anesthesia ComplicationChemotherapy-Induced Nausea and VomitingFasting StateFedHealthyHemodynamic InstabilityIleus ParalyticLeukemia

Phase 1

Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition

CompletedNCT01511718

Dr. Reddy's Laboratories LimitedHealthy

Start: 2006-10-31End: 2006-10-31Updated: 2012-01-19

Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition

CompletedNCT01511705

Dr. Reddy's Laboratories LimitedHealthy

Start: 2006-10-31End: 2006-10-31Updated: 2012-01-19

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition

CompletedNCT01578265

IPCA Laboratories Ltd.Fed

Start: 2011-05-31End: 2011-09-30Updated: 2012-04-16

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

CompletedNCT01578252

IPCA Laboratories Ltd.Fasting State

Start: 2011-05-31End: 2011-09-30Updated: 2012-04-16

Phase 2

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

CompletedNCT00104403

GlaxoSmithKlineChemotherapy-Induced Nausea and Vomiting, Nausea and Vomiting, Chemotherapy-Induced

Start: 2004-12-31End: 2006-01-31Updated: 2015-04-16

Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy

TerminatedNCT00429702

University of South FloridaNausea, Unspecified Childhood Solid Tumor, Protocol Specific, Vomiting

Start: 2007-10-31End: 2009-11-30Updated: 2014-07-25

Phase 3

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

CompletedNCT03578081

Alliance for Clinical Trials in OncologyMalignant Neoplasm

Start: 2018-11-20End: 2023-05-01Updated: 2025-04-06

Phase 4

Laparoscopic Cholecystectomy: General Anesthesia With Opioid Versus General Opioid Free Anesthesia

NCT02953210

Federal University of São PauloAnesthesia Complication, Hemodynamic Instability, Ileus Paralytic +3

Start: 2016-11-30End: 2017-03-31Target: 40Updated: 2016-11-04

Unknown Phase

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

CompletedNCT00343863

University of WashingtonMale Breast Cancer, Nausea and Vomiting, Stage I Breast Cancer +2

Start: 2006-01-31End: 2010-12-31Updated: 2017-07-11

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

WithdrawnNCT00499668

Vanderbilt-Ingram Cancer CenterLeukemia, Lymphoma, Lymphoproliferative Disorder +5

Start: 2007-08-31End: 2008-03-31Updated: 2013-04-02

Related Papers

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)

The Oncologist2023-06-071 citations

Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III randomized, double-blind, placebo-controlled trial (ALLIANCE A221602).

Journal of Clinical Oncology2022-06-011 citations